A new study identified protein targets and drug candidates, including opportunities to repurpose existing drugs. Six key ...

Using the approved multiple sclerosis therapy Kesimpta helps keep relapsing MS stable over time for most adults, a real-world ...

Early trial data support quarterly dosing of an under-the-skin Briumvi formulation now being tested in Phase 3 for relapsing ...

Groundbreaking new NHS treatment sees patients go into remission - The therapy works by genetically modifying cells to enable ...

Scientists have uncovered two fresh sub-types of multiple sclerosis (MS) that could open doors to innovative treatments. Utilising artificial intelligence (AI), researchers examined brain scans ...

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition. A study led by the University of ...

The US Food and Drug Administration (FDA) has granted approval to Biogen Idec's new multiple sclerosis (MS) treatment Tecfidera (dimethyl fumarate capsules), clearing the way for the company to market ...

An MS disease activity score test was found to be effective in monitoring underlying disease activity specific to ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with the disease worldwide. As MS is an ...

A cross-section of the spinal cord showing neurons and glial cells. (Juan Carlos Juarez Jaramillo/iStock/Getty Images Plus) A ...

New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of ...

The first revision of the McDonald criteria in nearly a decade could improve diagnostic speed and accuracy in multiple sclerosis (MS), reducing the period of uncertainty and permitting earlier start ...